Site Menu
Search Close Search
Search Close Search
Page Menu

Jonathan M. Gerber, MD

Research Focus - Translational Research in Leukemia

  • Translational laboratory focus on leukemia stem cells, including identification and targeting, minimal residual disease assays, and phenotype and response
  • Early-phase clinical investigation, including research on novel agents to target leukemia stem cells, predictors of response, and lab correlates of clinical trials

Representative Publication

Gerber JM, Smith BD, Ngwang B, et al. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood. 2012;119(15):3571-3577.

Read Publication

More Publications

Clinical Trials

View more trials at Conquering Diseases

In the News

Getting Results…
  • Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Vaccination against COVID-19 was linked to reduced inflammation in response to SARS-CoV-2 infection, according to a paper co-authored by UMass Chan Medical School researcher Jonathan M. Gerber, MD.

    Read more
  • Jonathan Gerber named director of UMass Cancer Center; Michelle Kelliher interim chair of molecular, cell & cancer biology

    Jonathan Gerber named director of UMass Cancer Center; Michelle Kelliher interim chair of molecular, cell & cancer biology

    As the UMass Chan mourns the recent death of Michael Green, MD, PhD, two faculty have been appointed to fill positions that Dr. Green nobly held. Jonathan M. Gerber, MD, has been appointed director of the UMass Cancer Center, and Michelle A. Kelliher, PhD, will serve as interim chair of the Department of Molecular, Cell & Cancer Biology.

    Read more
  • New research shows effectiveness of COVID-19 convalescent plasma in reducing hospitalization

    New research shows effectiveness of COVID-19 convalescent plasma in reducing hospitalization

    A large, double-blind, randomized controlled trial found that outpatients who received convalescent plasma within nine days of onset of COVID-19 symptoms were significantly less likely to be hospitalized than those who received placebo control plasma.

    Read more
  • UMass Chan researcher explains convalescent plasma’s potential as COVID-19 treatment

    UMass Chan researcher explains convalescent plasma’s potential as COVID-19 treatment

    Jonathan Gerber, MD, discusses a therapy that has been around for at least a century and how it has helped in the COVID-19 pandemic.

    Read more
  • UMass Cancer Walk and Run chosen as best local fundraiser event by WBJ readers

    UMass Cancer Walk and Run chosen as best local fundraiser event by WBJ readers

    Worcester Business Journal readers have chosen the UMass Cancer Walk and Run as the best nonprofit fundraiser event in Central Massachusetts.

    Read more
  • Early use of convalescent plasma treatment for COVID-19 helps avoid hospitalization

    Early use of convalescent plasma treatment for COVID-19 helps avoid hospitalization

    Results of a clinical trial led by Jonathan M. Gerber, MD, suggest that early use of convalescent plasma treatment for COVID-19 helps avoid hospitalization.

    Read more
  • UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    More than 100 critically ill COVID-19 patients in the UMass Memorial Health Care system have been treated with convalescent plasma through a UMass Medical School clinical trial led by Jonathan M. Gerber, MD.

    Read more
  • Cancer deaths decline in United States, with advances in prevention, detection and treatment

    Cancer deaths decline in US, with advances in prevention, detection and treatment

    In an essay originally published by The Conversation, Cancer Center Director Jonathan Gerber, MD, discusses the specifics of recently reported declines in cancer deaths and provides perspective for future continued progress.

    Read more
  • LISTEN: Jonathan Gerber on next-generation therapies to fight cancer

    LISTEN: Jonathan Gerber on next-generation therapies to fight cancer

    Learn about the UMass Cancer Walk and Run and the latest advancements in cancer research in this Voices of UMassMed podcast with Jonathan Gerber, MD.

    Read more
  • Stories of loss, survival and hope at the 2019 UMass Cancer Walk Kickoff

    Stories of loss, survival and hope at the 2019 UMass Cancer Walk Kickoff

    At an event characterized by a mix of smiles and tears, the race to raise money for the 2019 UMass Cancer Walk and Run officially began on June 3 as more than 100 team leaders, cancer survivors and event sponsors gathered at the Albert Sherman Center.

    Read more